Invasive Saccharomyces Infection: A Comprehensive Review
The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Saccharomyces cerevisiae (also known as "baker's yeast" or "brewer's yeast") is mostly considered to be an occasional digestive commensal. However, since the 1990s, there have been a growing number of reports about its implication as an etiologic agent of invasive infection. A particular feature of such infections is their association with a probiotic preparation of Saccharomyces boulardii (a subtype of S. cerevisiae) for treatment various diarrheal disorders. METHODS: We collected published case reports, through May 2005, of invasive Saccharomyces infection by use of a Medline query. Epidemiological and clinical charts and therapeutic strategies were analyzed. RESULTS: We found 92 cases of Saccharomyces invasive infection. Predisposing factors were similar to those of invasive candidiasis, with intravascular catheter and antibiotic therapy being the most frequent. Blood was the most frequent site of isolation (for 72 patients). S. boulardii accounted for 51.3% of fungemias and was exclusively isolated from blood. Compared with patients infected with S. cerevisiae, patients infected with S. boulardii were more frequently immunocompetent and had a better prognosis. Saccharomyces invasive infection was clinically indistinguishable from an invasive candidiasis. Overall, S. cerevisiae clinical isolates exhibited low susceptibility to amphotericin B and azole derivatives. However, global outcome was favorable in 62% of the cases. Treatment with intravenous amphotericin B and fluconazole, in combination with central vascular catheter removal, were effective therapeutic options. CONCLUSION: Saccharomyces organisms should now be added to the growing list of emerging fungal pathogens. Special caution should be taken regarding the use of S. boulardii probiotic preparations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple cases of disseminated infection have been identified in apparent association with this probiotic, particularly in immune-suppressed individuals (39).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [39]
In the citing paper
“In a few case studies, however, S. cerevisiae has been implicated in catheter-associated infections with mixed-species biofilms in patients in intensive care units (ICUs)”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
In the citing paper
“and it is able to form a thin biofilm consisting of round, budding yeast-form cells and pseudohyphal cells in vitro (26, 50, 128, 164).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“We only considered proven infection, based on the definitions of the Invasive Fungal Infection Cooperative Group of the European Organization for Research and Treatment of Cancer–Mycosis Study Group of the National Institute of Allergy and Infectious Diseases cooperative group [19]: fungemia, isolation from normally s…”
MethodNEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Medical Mycology. The Pathogenic Fungi and Pathogenic Actinomycetes.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-4-514_1 · Cited by 847
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“Despite this spectrum of susceptibility, a favorable outcome was observed in 63% of cases revealed in our literature search, which is a slightly higher percentage than that reported for cases of invasive candidiasis [87].”
ResultProtection from gastrointestinal diseases with the use of probiotics
Marteau, P. R., Vrese, M. D., Cellier, C. J., & Schrezenmeir, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.430s · Cited by 596
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“35[77] 76 years, F DNA fingerprinting Diabetes, heart surgery No Yes Yes Yes FLU NS Death 36 [771 72 years, F DNA fingerprinting Heart surgery No Yes Yes Yes None NS Death 37 [77] 74 years, F DNA fingerprinting Rheumatoid arthritis, corticosteroid therapy, heart surgery NS No Yes Yes FLU NS Death”
BackgroundFUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE
EUBINSTE1N, E., NOKIEGA, E. R., SIMBEEKOFF, M. S., HOLZMAN, E., & RAHAL, J. J. (1975) · Medicine · doi:10.1097/00005792-197507000-00003 · Cited by 275 · cited 1×
“1 [231 54 years, F Blood Urine Diphtheroids Valvular prosthesis No Yes Yes AmB Yes Favorable 2 [24] 38 years, M .”
BackgroundNew Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J., & Rolston, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 259
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann-Lacroix, C., Jobert, A., Viard, J. P., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253 · cited 5×
“Hand transmission has been suggested in these latter cases [5].”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 9
- 2001, 11, 19
- Rubinstein, 1975, Medicine, 54, 331
- Eschete, 1980, Archives of Internal Medicine, 140, 1539, 10.1001/archinte.1980.00330220085032 · doi:10.1001/archinte.1980.00330220085032
- 1997, Bulletin de la Soci t de pathologie exotique (1990), 90, 307
- Pavese, 1999, Pathologie-biologie, 47, 579
- Feld, 1982, The Journal of Rheumatology, 9, 637
- Kirsch, 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 34, 229
- Zunic, 1991, Th rapie, 46, 498
- Pletincx, 1995, Journal of pediatric gastroenterology and nutrition, 21, 113, 10.1097/00005176-199507000-00022 · doi:10.1097/00005176-199507000-00022 · Paper page
Cited by
Items 301–368 of 368
Koh, J. Y., Seo, E., & Lee, J. (2017) · Pediatric Infection & Vaccine · doi:10.14776/piv.2017.24.3.168 · Cited by 1
Çolak, M. Y., & Aşgın, N. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.910783 · Cited by 1
“Saccharomyces infections remain rare among invasive fungal infections, although the incidence has significantly increased since the 1990s [27].”
BackgroundOther Invasive Yeast Infections
Richardson, M. D., & Warnock, D. W. (2012) · doi:10.1002/9781118321492.ch26 · Cited by 1
Evolutionary Implications and Genetic Basis of Peroxide Survival in Saccharomyces cerevisiae
Diezmann, S. (2009) · DukeSpace (Duke University) · Cited by 1
Probiotics in infectious diarrhoea: are they indicated? A review focusing on Saccharomyces boulardii
Vandenplas, Y., Nel, E., Watermeyer, G., Walele, A., Wittenberg, D. F., & Zuckerman, M. J. (2007) · South African Journal of Child Health · Cited by 1
Etifa, P. (2021) · University of Hertfordshire Research Archive (University of Hertfordshire) · doi:10.18745/th.23919 · Cited by 3
Clostridium difficile Infections and their Treatment
Mattila, E. J. (2013) · Helda - University of Helsinki Institutional Repository
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pépin, J., & Wilcox, M. H. (2011)
Zupan, J., Matos, T., Čenčič, A., & Raspor, P. (2013) · Zbornik Matice srpske za prirodne nauke · doi:10.2298/zmspn1324379z · Cited by 1
Reshuffling transcriptional circuits: how microorganisms adapt to colonize the human body
De, S., & Pérez, J. C. (2014) · Transcription · doi:10.4161/21541264.2014.976095
Dugoua, J.-J., Machado, M., Zhu, X., Chen, X., Koren, G., & Einarson, T. R. (2009)
Emerging Systemic Yeast Pathogens
Mathews, M. S., & Ashbee, H. R. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_11
Present and Future Management Options for Clostridium difficile Infection
Gerding, D. N. (2009)
Application of Microarrays for Laboratory Detection and Identification of Medically Important Fungi
Chang, T. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3970-7_39
McKenzie, K. (2014) · STAX · doi:10.48730/qks2-a542 · Cited by 1
Tambot, H. G., Yu, I., Cutrona, A. F., & Marnejon, T. P. (2010) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e3181b9d31d
“This has been well documented with Saccharomyces boulardii.(28) Treatment of Lactobacillus infection is usually with a penicillin.”
MethodClostridium difficile infection: review with special interest in hematologic patients
Oksi, J. (2014) · Drugs and Cell Therapies in Hematology · doi:10.4081/dcth.2014.63
Probiotics in Inflammatory Bowel Disease: Yet Another Mechanism of Action?
Paulson, E. C., Niedzwiecki, D., Davis, W., Bosworth, H., Sanders, L., Jurng-Jae, Y., Henderson, J., Hatten, P., Burdick, S., Sanyal, A. J., et al. (2009)
Le Clostridium difficile dans les populations d’âge pédiatrique
Upton, D. A., de pédiatrie, S. C., & d’immunisation, C. D. M. I. E. (2014) · Paediatrics & Child Health · doi:10.1093/pch/19.1.49 · Cited by 1
Valenti, A. J., & Wilcox, M. H. (2007) · CRC Press eBooks · doi:10.1201/b15169-11
Gut Microbiome in the Critically Ill
Cresci, G. (2015) · CRC Press eBooks · doi:10.1201/b18386-13
A Case of Chronic Cough in a Winemaker
Viteri, E., FORAY, N. E., Song, M., & Long, D. (2017) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2017.03.014
“CT scan of chest was unremarkable except for multiple small nonspecific mediastinal and hilar lymph nodes and minimal lingular atelectasis.”
MethodThe importance of probiotics in antibiotic associated diarrhea
Duman, M., & Çağlar, A. (2017) · Journal of Dr Behcet Uz Children s Hospital · doi:10.5222/buchd.2017.001
“Spesifik antibiyotik tedavisi ile birlikte probiyotiklerin kullanılmasını destekleyen yeterli veri olmaması, immunsuprese ve kateteri olan kritik hastalarda sepsis bildirilmesi nedeni ile rutin kullanımı önerilmemektedir (32-34).”
BackgroundMizutani, T., Ohkusu, K., Terachi, T., Sawa, K., & Akagi, M. (2017) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.91.31
Willaert, R. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-432-1
Singh, N. K., & Klontz, K. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00190-0
Saccharomyces Kluyveri Fungemia in a Patient with Human Immunodeficiency Virus Infection
E., E. E., Hammami, M., Marrekchi, C., Cheikhrouhou, F., Trabelsi, H., Maalej, M., Hammami, B., Maâloul, I., Ayedi, A., Lahiani, D., et al. (2018) · Journal of Fungal Diversity · doi:10.14302/issn.2766-869x.jfd-18-2276
Non-antibiotic management for Clostridium difficile infection
Sood, A., & Vaishnavi, C. V. (2016) · JOURNAL OF GASTROINTESTINAL INFECTIONS · doi:10.5005/jp-jogi-6-1-3 · Cited by 1
Cryptococcosis and other rare invasive yeasts infections
Lee, P., & Goldman, D. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-64198-2.00036-1 · Cited by 1
Colitis por Clostridium difficile
Efron, P. A., & Mazuski, J. E. (2009) · Clínicas quirúrgicas de Norteamérica
Roeske, K., Kuryłek, A., Cieślik, J., Wróblewska, M., & Jagielski, T. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.3.21
Hernández‐Haro, C., Monteoliva, L., Molero, G., Garcia, C. G., & Molina, M. (2010) · Universidad de Córdoba Insitutional Repository (Universidad de Córdoba)
Fungal Infections Complicating COVID-19
Hoenigl, M., & Talento, A. F. (2021) · MDPI eBooks · doi:10.3390/books978-3-0365-0555-8
Infection Due to Non-Candidal Yeasts
Vazquez, J. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-325-7_8
Alanio, A., & Chen, S. C.-A. (2020) · Hematologic malignancies · doi:10.1007/978-3-030-57317-1_15
Walsh, T. J., Hayden, R. T., & Larone, D. H. (2018) · ASM Press eBooks · doi:10.1128/9781555819880.biblio
Zhang, S. X., & Wiederhold, N. P. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch15
Rowen, J. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50224-7
(2014) · ASM Press eBooks · doi:10.1128/9781555817152.refs
Plotkin, J. B. (2009) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1157966.618045
Bishop, J. A., & Merz, W. G. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch11
(2012) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-012-0177-1
Velez, A. P., Lamarche, J. A., & Greene, J. N. (2019) · Springer eBooks · doi:10.1007/978-3-030-21859-1_7
Dupont, A. W., & Khurana, S. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732670634.793579191
Hube, B., & Brunke, S. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727562646.793538535
Owens, R. C., Valenti, A. J., & Wilcox, M. H. (2007) · Infectious disease and therapy · doi:10.3109/9781420017236.011
Mujawdiya, P. K., Pandey, P., Singh, R., Sharad, S., & Kapur, S. (2022) · ACTA SCIENTIFIC MICROBIOLOGY · doi:10.31080/asmi.2022.05.1126
Prevention of Infantile Colic Using Probiotics
Ahanchian, H., & Javid, A. (2018) · EMJ Gastroenterology · doi:10.33590/emjgastroenterol/10310441
Saccharomyces cerevisiae strain Boulard
Margina, D. M., & Purdel, C. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824315-2.00089-0
Agentes microbianos reguladores da microbiota intestinal humana e animal: uma abordagem geral
Pinto, C. D. P., Paulo, E. M., Kamida, H. M., Pinheiro, C. S. R., & Uetanabaro, A. P. T. (2007) · SITIENTIBUS série Ciências Biológicas · doi:10.13102/scb8112
Gonsalez, C. R., da Silva, G. P., Ralio, R. B., Santos, N. T., Boccardo, E. J., Medeiros, L. A., & Mendonça, M. (2023) · Seven Editora eBooks · doi:10.56238/devopinterscie-213
Larone, D. H., Westblade, D. L. F., Burd, D. E. M., Lockhart, D. S. R., Procop, G. W., & Walsh, T. J. (2023) · Wiley eBooks · doi:10.1002/9781683674436.ref
Infections Due to Non-Candidal Yeasts
Colombo, R. E., & Vázquez, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-35803-6_10 · Cited by 1
Что надо знать о редко встречающихся возбудителях инфекций у онкологических больных?
Николаевна, П. И., Grigorievskaya, Z. V., Bagirova, N. S., & Агинова, В. В. (2024) · Malignant tumours · doi:10.18027/2224-5057-2024-14-3s1-72-79
Urbán, C. T., Sichani, S. B., Modaffore, G. U., Glorieux, C., Gruber, J., Yongabi, D., Lettinga, M. P., & Wagner, P. (2025) · Sensors · doi:10.3390/s25092902
“This compound binds to ergosterol in the yeast cell membrane [31–34].”
Current Trends in Biomarkers and Diagnosis of Prevalent Neurological Infectious Diseases
Verma, K., Priyanka, Singh, S., & Yadav, N. (2026) · IGI Global eBooks · doi:10.4018/979-8-3693-4070-7.ch007
Stefani, H. J., Morisaki, D. H., Ch., B. O., Adusumilli, M. B., Porras, A. L., Albukhari, M., & Ayoade, F. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-12764-2
“While fluconazole is more convenient and better tolerated, the use of voriconazole from the outset might have been more appropriate given the potential for invasive fungal disease and the general poor susceptibilities reported to fluconazole for S. cerevisiae [18–20].”
Couturier, J. (2020) · theses.fr (ABES) · doi:10.70675/fe4590c9z9e1bz4fdez88fcz8e8c0a9023e4 · Cited by 1
Concentration and fractionation by membranes of spent brewer's yeast protein hydrolysate
Marson, G. V. (2020) · theses.fr (ABES) · doi:10.70675/0b963263z7dbfz4147z8e88z644063503c9a
Development and Differentiation of Yeast Colonies and Biofilms
Palková, Z., & Váchová, L. (2026) · The mycota · doi:10.1007/978-3-032-15548-1_6
Yao, Z., He, K., Wang, H. T., Suryoprabowo, S., Yao, N., Wu, Q. J., & Wang, L. (2026) · Small · doi:10.1002/smll.74416
Sadrimovahed, M., & Ulusoy, B. H. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.109934
Mishra, S., & Saxena, S. K. (2026) · Clinical Pediatrics · doi:10.1177/00099228261480530
Potes, J. P. P., Ospina, J. D. U., Idrobo, E. S. P., Torres, E. A. O., Loaiza, J. V., Loaiza, I. V., Andrade, J. D. G., Solarte, D. F. F., & Ortíz-Erazo, W. F. (2026) · Cureus · doi:10.7759/cureus.118535
Metadata
- Authors
- Enache-Angoulvant, A., & Hennequin, C.
- Affiliations
- Hôpital Tenon (FR)
- Corresponding author
- Hennequin, C.
- ORCID
- Hennequin, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 41
- Issue
- 11
- Pages
- 1559-1568
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168407031
- Cited by
- 369
- References
- 88
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 10 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 23 · 2017: 34 · 2016: 19 · 2015: 23 · 2014: 14 · 2013: 23 · 2012: 18
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Saccharomyces cerevisiae, Saccharomyces boulardii, invasive candidiasis, fungemia, emerging fungal pathogens, amphotericin B susceptibility, fluconazole, central venous catheters, antibiotic therapy, immunocompetent patient
- MeSH terms
- Female, Humans, Male, Mycoses, Risk Factors, Saccharomyces
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.